Toward universal human papillomavirus vaccination for adolescent girls in Hong Kong: a policy analysis
- PDF / 983,675 Bytes
- 15 Pages / 439.37 x 666.142 pts Page_size
- 4 Downloads / 155 Views
Toward universal human papillomavirus vaccination for adolescent girls in Hong Kong: a policy analysis Ruirui Chen1 · Eliza Wong2 · Lijuan Wu1 · Yuanfang Zhu1
© The Author(s) 2020
Abstract Studies have assessed early population-level impact of human papillomavirus (HPV) vaccination programs for preventing cervical cancer. Through a case study in Hong Kong we examined stakeholder engagement and interactions to promote a universal HPV vaccination program using the Health Policy Triangle framework for structured health policy analysis. Using data from a document review and semi-structured in-depth interviews, we used thematic and stakeholder analyses to describe the process of policy formation. Given Hong Kong’s political and health system, and a mix of Chinese and Western values, stakeholders judged legitimacy of the process differently. We discuss their varied ethical stances and the role of research evidence for informing policy-making. For effective HPV vaccination policy and promotion of universal free HPV vaccination among adolescent girls, new strategies are needed to broaden acceptance of the process, to frame policies in terms of facts and values, and to connect research to policy-making and improve coalition-building. Keywords HPV vaccination · Universal coverage · Health policy analysis · Hong Kong · Stakeholder analysis
Introduction Countries with sufficient resources have successfully implemented human papillomavirus (HPV) vaccination programs with high rates of uptake among adolescent girls [1]. A recent systematic review assessed early population-level impact on reductions in HPV vaccine-type prevalence, genital wart diagnoses, pre-cancer high grade cervical lesions, and herd immunity [2]. A World Health Organization (WHO) position paper in 2014 recommended that all countries should try to integrate HPV * Ruirui Chen [email protected] 1
Jinan University-affiliated Shenzhen Baoan Women’s and Children’s Hospital, Shenzhen, China
2
Division of Health System, Policy & Management, School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong
Vol.:(0123456789)
R. Chen et al.
vaccine into their national immunization programs to prevent cervical cancer or other HPV-related diseases, and to ensure that vaccination is programmatically feasible, cost-effective, and sustainable [3]. In Australia, HPV vaccination is a part of routine school-based immunization program, delivered free of charge for all sexes aged 12–13 years. In the United States, case studies delved into the politics of HPV vaccination policy formation [4, 5]. Other studies examined HPV vaccination in Asian countries, including issues such as financing, policy development, and the feasibility of a government-implemented program [6–8]. Still lacking, however, was a structured analysis of political dimensions of policy-making, in which the use of frameworks could guide analysis, deepen understanding, and support generalization to other settings targeting universal HPV vaccination. Walt and Gilson deve
Data Loading...
